Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in Apellis Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 302
- +20 vs. Q4 2023
- Shares held
- 113.1M
- −619.3K (−0.5%) vs. Q4 2023
- Total value
- $6.65B
- −$166.2M (−2.4%) vs. Q4 2023
- New holders
- 66
- 105 more added
- Sold out
- 46
- 91 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $10.2K |
| Q1 2026 | 324 | $5.56B |
| Q4 2025 | 280 | $3.17B |
| Q3 2025 | 273 | $2.77B |
| Q2 2025 | 247 | $2.28B |
| Q1 2025 | 255 | $2.80B |
| Q4 2024 | 260 | $4.04B |
| Q3 2024 | 265 | $3.41B |
| Q2 2024 | 263 | $4.43B |
| Q1 2024 | 302 | $6.65B |
| Q4 2023 | 284 | $6.82B |
| Q3 2023 | 256 | $4.34B |
| Q2 2023 | 317 | $9.71B |
| Q1 2023 | 282 | $7.28B |
| Q4 2022 | 244 | $5.20B |
| Q3 2022 | 250 | $6.66B |
| Q2 2022 | 212 | $4.15B |
| Q1 2022 | 212 | $4.62B |
| Q4 2021 | 187 | $3.83B |
| Q3 2021 | 181 | $2.29B |
| Q2 2021 | 205 | $4.08B |
| Q1 2021 | 175 | $2.80B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quest Partners LLC | 1 | $59 | 0.00% | +1 | New |
| Proequities, Inc. | 1 | $58 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −253,905−100.0% | Sold out |
| Great Lakes Advisors, LLC | 0 | $0 | 0.00% | −208,163−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −114,069−100.0% | Sold out |
| Cutter Capital Management, LP | 0 | $0 | 0.00% | −108,000−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −97,716−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −76,100−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −66,470−100.0% | Sold out |
| Agf Management Ltd | 0 | $0 | 0.00% | −58,496−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −49,900−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −44,954−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −41,521−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −39,392−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −33,086−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −17,275−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −17,093−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −15,342−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −15,008−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −14,772−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −14,695−100.0% | Sold out |
| Portman Square Capital LLP | 0 | $0 | 0.00% | −14,053−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −12,831−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −11,609−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −10,677−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −10,201−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −9,962−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −9,913−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −8,240−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −7,249−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −6,443−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −5,235−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −4,340−100.0% | Sold out |
| Sierra Summit Advisors LLC | 0 | $0 | 0.00% | −3,714−100.0% | Sold out |
| Henshaw Capital LLC | 0 | $0 | 0.00% | −3,595−100.0% | Sold out |
| HC Advisors, LLC | 0 | $0 | 0.00% | −3,507−100.0% | Sold out |
| CWA Asset Management Group, LLC | 0 | $0 | 0.00% | −3,425−100.0% | Sold out |
| Torno Capital, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −490−100.0% | Sold out |
| Turtle Creek Wealth Advisors, LLC | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| LM Advisors LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −123−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Sawtooth Solutions, LLC | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |